COPD Clinical Trials near Houston, TX
17 studies for COPD are recruiting at 48 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all COPD trials in the US or all trials near Houston.
Recruiting now
COPD studies enrolling near Houston
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Baylor College of Medicine- Site Number : 8400076 (Houston, TX); Gulf Coast Clinical Research - Houston- Site Number : 8400049 (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 8 sites within 50 mi
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
NCT07177339
- Phase 3
- Ages 40 to 75 years
- Sex: All
Nearest sites: GSK Investigational Site (Houston, TX); GSK Investigational Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Aavon Clinical Trials, Llc- Site Number : 8400166 (Houston, TX); Se Houston- Site Number : 8400120 (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Houston, TX); Research Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
NCT06959095
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: GSK Investigational Site (Houston, TX); GSK Investigational Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Houston, TX); Research Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Houston, TX); Research Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: GSK Investigational Site (Houston, TX); GSK Investigational Site (Webster, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694
- Phase 2/3
- Ages 35 to 80 years
- Sex: All
Nearest sites: Greater Heights & Memorial Pulmonary and Sleep (Houston, TX); Houston Pulmonary Sleep and Allergy Associates (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
NCT07612878
- Observational
- Ages 40 years and older
- Sex: All
Nearest sites: The Respire Institute (Houston, TX); Activian Clinical Research (Kingwood, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888
- Interventional
- Ages 30 years and older
- Sex: All
Nearest site: Respire Research Institute (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077
- Observational
- Ages 50 years and older
- Sex: All
Nearest site: Horizon Clinical Research Group (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755
- Interventional
- Ages 40 to 84 years
- Sex: All
Nearest site: Houston Methodist/Primary Critical Care (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
NCT07059091
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest site: Baylor College of Medicine (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest site: Research Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
NCT07684820
- Phase 2
- Ages 40 to 85 years
- Sex: All
Nearest sites: Horizon Clinical Research Group. (Cypress, TX); DM Clinical Research- Tomball (Tomball, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
NCT07725939
- Phase 2
- Ages 40 to 80 years
- Sex: All
Nearest site: Copd01 50005 (Tomball, TX)
- Distance to nearest recruiting site
- ~28 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a COPD clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.